The effects of sodium valproate on disturbed behavior in dementia. 1994

R C Sival, and P M Haffmans, and P P van Gent, and J F van Nieuwkerk

UI MeSH Term Description Entries
D008297 Male Males
D003704 Dementia An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness. Senile Paranoid Dementia,Amentia,Familial Dementia,Amentias,Dementia, Familial,Dementias,Dementias, Familial,Dementias, Senile Paranoid,Familial Dementias,Paranoid Dementia, Senile,Paranoid Dementias, Senile,Senile Paranoid Dementias
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D001519 Behavior The observable response of a man or animal to a situation. Acceptance Process,Acceptance Processes,Behaviors,Process, Acceptance,Processes, Acceptance
D014635 Valproic Acid A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. Dipropyl Acetate,Divalproex,Sodium Valproate,2-Propylpentanoic Acid,Calcium Valproate,Convulsofin,Depakene,Depakine,Depakote,Divalproex Sodium,Ergenyl,Magnesium Valproate,Propylisopropylacetic Acid,Semisodium Valproate,Valproate,Valproate Calcium,Valproate Sodium,Valproic Acid, Sodium Salt (2:1),Vupral,2 Propylpentanoic Acid

Related Publications

R C Sival, and P M Haffmans, and P P van Gent, and J F van Nieuwkerk
October 2010, Geriatrics & gerontology international,
R C Sival, and P M Haffmans, and P P van Gent, and J F van Nieuwkerk
October 1992, International journal of immunopharmacology,
R C Sival, and P M Haffmans, and P P van Gent, and J F van Nieuwkerk
January 1993, Journal of geriatric psychiatry and neurology,
R C Sival, and P M Haffmans, and P P van Gent, and J F van Nieuwkerk
July 1992, Nederlands tijdschrift voor geneeskunde,
R C Sival, and P M Haffmans, and P P van Gent, and J F van Nieuwkerk
June 1987, Neuropharmacology,
R C Sival, and P M Haffmans, and P P van Gent, and J F van Nieuwkerk
January 1992, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
R C Sival, and P M Haffmans, and P P van Gent, and J F van Nieuwkerk
September 1983, The Journal of pediatrics,
R C Sival, and P M Haffmans, and P P van Gent, and J F van Nieuwkerk
June 1977, British medical journal,
R C Sival, and P M Haffmans, and P P van Gent, and J F van Nieuwkerk
March 1980, Neurology,
R C Sival, and P M Haffmans, and P P van Gent, and J F van Nieuwkerk
March 1981, The Medical journal of Australia,
Copied contents to your clipboard!